Post-Marketing Safety Study in ST-Segment Elevation Myocardial Infarction (STEMI) Participants Undergoing Primary Percutaneous Coronary Intervention (PCI) Procedure With VISIPAQUE® as the Contrast Medium

Exclusion Criteria

• •Participants must be excluded from participating in this study if they meet any of the following criteria:
• •The participant has any contraindications to Visipaque (e.g., manifest thyrotoxicosis, history of serious hypersensitivity reaction to iodinated contrast media)
• •The participant is pregnant or lactating
• •The participant has been previously enrolled in this study
• •The participant is currently under renal dialysis
• •The participant presents with a terminal (life expectation \<1 month), serious, or life-threatening disease, or any medical or psychiatric condition, or any condition where study participation may compromise the management of the participant
• •The participant has other reasons that in the judgement of the investigator is unsuitable for participation in the study